http://www.g1therapeutics.com
G1 Therapeutics, Inc. Company Intro
G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer.
Industry
Healthcare
G1 Therapeutics, Inc. Headquaters
700 Park Offices Drive
Research Triangle Park,27709
United States
G1 Therapeutics, Inc. Share price
17 May 2023 13:17 GMT
$2.8800
-0.04 (-1.37 %)
G1 Therapeutics, Inc. Market cap
$140 M
WMC RANKING
2023
G1 Therapeutics, Inc. # 122
BiotechnologyLatest G1 Therapeutics, Inc. News
05 Dec 2023
Nothing is Better Than Apollomics Inc (APLM) stock at the ...
G1 Execution Services LLC is the third largest shareholder in APLM, holding ... With a 0.04% stake in APLM, the Range Cancer Therapeutics ETF is the largest...
05 Dec 2023
G1 Therapeutics, Inc. (NASDAQ:GTHX) Receives Consensus ...
G1 Therapeutics, Inc, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics...
05 Dec 2023
Triple Negative Breast Cancer Pipeline, FDA Approvals ...
Shanghai Henlius Biotech · Jiangsu HengRui Medicine Co., Ltd. · G1 Therapeutics, Inc. · Infinity Pharmaceuticals · HiberCell, Inc.
WMC Market Score
WMC Market to Revenue Score
G1 Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| G1 Therapeutics, Inc. | USD | $59,503 | $149,450 | $-94,673 | $1,400M | 122 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total G1 Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Post vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
G1 Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
G1 Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| G1 Therapeutics, Inc. | 0.65 | 3.79 | 0.02 | 0 | 0 | 0 | 1.64 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
